Screening and management of metabolic complications of mTOR inhibitors in real-life settings

Pamela Spanjaard,Jean Michel Petit, Antonin Schmitt,Bruno Vergès,Benjamin Bouillet

Annales d'Endocrinologie（2023）

引用 0|浏览7

暂无评分

摘要

•Few studies have evaluated the effect of mTORi on metabolic complications in real-life settings.•The incidence of diabetes under mTORi was 9%.•Remission of diabetes after mTORi discontinuation concerns patients not receiving antidiabetic treatment.•Screening for dyslipidemia was insufficient.

查看译文

关键词

mTOR inhibitors,Metabolic complications,Dyslipidemia,Diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要